TAMARA WELLMAN: Open Payments
NPI 1700084480 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 30 payments from 12 companies in 2025. Trend: 2023 $1,331 · 2024 $1,237 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $326 |
| Axsome Therapeutics, Inc. | 6 | $283 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $110 |
| Novo Nordisk Inc | 3 | $71 |
| Lilly USA, LLC | 2 | $37 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $22 |
Products named: VRAYLAR, Auvelity, Kerendia, CAPLYTA, Ozempic, MOUNJARO, NURTEC ODT, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
